×

News publications and other organizations are encouraged to reuse Direct Relief-published content for free under a Creative Commons License (Attribution-Non-Commercial-No Derivatives 4.0 International), given the republisher complies with the requirements identified below.

When republishing:

  • Include a byline with the reporter’s name and Direct Relief in the following format: "Author Name, Direct Relief." If attribution in that format is not possible, include the following language at the top of the story: "This story was originally published by Direct Relief."
  • If publishing online, please link to the original URL of the story.
  • Maintain any tagline at the bottom of the story.
  • With Direct Relief's permission, news publications can make changes such as localizing the content for a particular area, using a different headline, or shortening story text. To confirm edits are acceptable, please check with Direct Relief by clicking this link.
  • If new content is added to the original story — for example, a comment from a local official — a note with language to the effect of the following must be included: "Additional reporting by [reporter and organization]."
  • If republished stories are shared on social media, Direct Relief appreciates being tagged in the posts:
    • Twitter (@DirectRelief)
    • Facebook (@DirectRelief)
    • Instagram (@DirectRelief)

Republishing Images:

Unless stated otherwise, images shot by Direct Relief may be republished for non-commercial purposes with proper attribution, given the republisher complies with the requirements identified below.

  • Maintain correct caption information.
  • Credit the photographer and Direct Relief in the caption. For example: "First and Last Name / Direct Relief."
  • Do not digitally alter images.

Direct Relief often contracts with freelance photographers who usually, but not always, allow their work to be published by Direct Relief’s media partners. Contact Direct Relief for permission to use images in which Direct Relief is not credited in the caption by clicking here.

Other Requirements:

  • Do not state or imply that donations to any third-party organization support Direct Relief's work.
  • Republishers may not sell Direct Relief's content.
  • Direct Relief's work is prohibited from populating web pages designed to improve rankings on search engines or solely to gain revenue from network-based advertisements.
  • Advance permission is required to translate Direct Relief's stories into a language different from the original language of publication. To inquire, contact us here.
  • If Direct Relief requests a change to or removal of republished Direct Relief content from a site or on-air, the republisher must comply.

For any additional questions about republishing Direct Relief content, please email the team here.

Supporting Cancer Care and Treatments Globally, Direct Relief Continues Work on World Cancer Day – and Beyond

News

Cancer

Young patients play at Muhimbili National Hospital, Paediatric Block, Dar es Salaam, Tanzania. The hospital was supported with Direct Relief-donated oncology therapies. (Photo by Daniel Msirikale for Direct Relief)

World Cancer Day is an international awareness day established in 2000 by the Union for International Cancer Control (UICC), to raise worldwide attention and inspire action for a cancer-free future.

Cancer is the second leading cause of death worldwide, claiming 10 million lives, 70% of which were residents of low-and-middle-income countries (LMICs), where access to early diagnosis and treatment are limited. Without significant interventions, this disparity is anticipated to grow with time. The incidence of cancer in Sub-Saharan Africa alone is projected to increase by more than 92% in 2040 (American Cancer Society). This past year, Direct Relief donated over $168.6 million in oncology products globally, both within the US and LMICs through signature oncology programs, disaster response, US Safety Net Support, and general healthcare provider support.

Highlights of Direct Relief’s Work in the Cancer Space

A pharmacist at Muhimbili National Hospital, Paediatric Block, Dar es Salaam, Tanzania, with Direct Relief-donated cancer medications. (Photo by Daniel Msirikale for Direct Relief)

Direct Relief partners with leading pharmaceutical and biotechnology companies, as well as global cancer institutions, to source and distribute lifesaving treatments for people who otherwise would not have access. For more than a decade, Direct Relief has supported people living with cancer in over 50 countries, providing more than 1.5 billion defined daily doses of cancer treatments and associated therapeutic agents.

  • Limited availability of resources for cancer care including cancer prevention screenings and treatment, particularly in LMICs, contributes to additional deaths each year. To address this, Direct Relief has partnered with pharmaceutical company, Amgen, and the City Cancer Challenge (C/Can), a partnership that supports cities around the world to improve access to quality, equitable cancer care, to advance access to cancer treatments in LMICs across Africa, Asia, and Latin America.
  • Through its partnerships with Amgen and C/Can, Direct Relief is working to improve health outcomes for breast cancer patients in Paraguay’s capital city of Asunción. In addition to delivering critical cancer diagnostics and treatments, the collaboration is engaging local stakeholders to strengthen health infrastructure, the healthcare workforce, surveillance capacity, and supportive care at Paraguay’s leading cancer treatment institutions.
  • A longtime partner of UICC, Direct Relief is also a Country Support Committee member of UICC’s Access to Oncology Medicines (ATOM) Coalition, which aims to address the barriers to affordability, availability, and appropriate use of oncology medicines in LMICs. This past year Direct Relief participated in a 3-day workshop hosted by ATOM in Ulaanbaatar, Mongolia, speaking to the importance of supply chain management.
  • Direct Relief also partners with Global Hematology Oncology Pediatric Excellence, or Global HOPE, an initiative of Texas Children’s Hospital and Baylor College of Medicine, and Teva Pharmaceuticals to expand access to lifesaving cancer therapies and improve the prognosis of children with cancer and blood disorders in sub-Saharan Africa. Since 2020, Direct Relief has provided more than 570,000 defined daily doses of critical cancer treatments in support of the initiative, reaching children with cancer in Botswana, Malawi, Tanzania, Rwanda, and Uganda. Looking ahead to 2025, the partnership is looking to expand support to new sites in Tanzania and Kenya.
  • In 2024, Direct Relief finalized an agreement with pharmaceutical company, Servier Pharmaceuticals, and the Children’s International Consortium on Acute Leukemia (C-ICAL) initiative to provide ongoing donations of an essential medication to treat Acute Lymphoblastic Leukemia (ALL). C-ICAL is a partnership between the American Society of Hematology (ASH) and the SickKids Caribbean Initiative that seeks to improve the care of pediatric patients with ALL in the Caribbean. This past year Direct Relief provided support to the Bahamas, Barbados, and Jamaica, and looks to expand support in the region.
  • Since 2016, Direct Relief has partnered with the AbbVie Foundation and Casa de la Amistad para Niños con Cáncer (CDLA), a humanitarian organization in Mexico City, to support under-resourced families of children with cancer. CDLA provides counseling, education, nutritional support, shelter, and transportation to help families overcome barriers to accessing and adhering to treatment. Together, Direct Relief, the AbbVie Foundation, and CDLA assist over 300 pediatric patients from rural communities by providing stipends for food, lodging, and transportation, reducing the financial burden of traveling to and receiving cancer care.

The organization remains committed to connecting patients with oncology treatments needed to maintain their health and wellbeing, wherever they are.

Giving is Good Medicine

You don't have to donate. That's why it's so extraordinary if you do.